THE LATEST WORD

Top Industry Stories -August 31, 2010

Posted on August 31st, 2010 | by Rxmedyn | No Comments »

Drug Makers on the Trail of an Alternative to Steroids

US Urges Nearly All to Get Flu Shots

Cough-Syrup Abuse by Kids May Draw FDA Restrictions for Pfizer, J&J Drugs

Glaxo, Valeant May Wait 3 More Months for U.S. FDA to Review Epilepsy Drug

US Patients ‘Wary of Drugmakers Influence over Doctors’

Read the rest of this entry »

Top Industry Stories – August 30, 2010

Posted on August 30th, 2010 | by Rxmedyn | No Comments »

High-Deductible Plans Grow, but Not Everyone Should Get on Board

Years Later, No Magic Bullet Against Alzheimer’s Disease

Sanofi Unveils Genzyme ‘Bear Hug’

Potential Cause of Asthma-Like Symptoms Spotted in Mice

Study Finds First Genetic Link to Common Migraine

Read the rest of this entry »

Top Industry Stories – August 27, 2010

Posted on August 27th, 2010 | by Rxmedyn | No Comments »

Estimate Lowered of Typical Flu Toll

Toeing a Thin Line with Foot Surgery

Are Allergies Associated with Heart Disease?

Stallergenes Set to Begin Looking for U.S. Partner, Chief Executive Says

AstraZeneca Pension Row Sparks Merger Speculation

Read the rest of this entry »

Top Industry Stories – August 26, 2010

Posted on August 26th, 2010 | by Rxmedyn | No Comments »

Antihistamine Use Linked to Extra Pounds

Sanofi Said To Be Unwilling to Raise Genzyme Bid Price

Patients in Clinical Trials to get Routine Care Covered

US Branded Drug Prices Up 8.3% in Just One Year

Consumers Anxious About Drug Costs, Industry Influence

Read the rest of this entry »

Top Industry Stories – August 25, 2010

Posted on August 25th, 2010 | by Rxmedyn | No Comments »

Stem Cell Ruling will be Appealed

Diabetes Drug Avandia Just as Safe as Actos: Study

Johnson & Johnson gets FDA Warning on Marketing

Foreign Drugmaker Buyouts Raise Concern in India, Financial Express Says

Accelerating Early Stage Drug Discovery with PAM

Read the rest of this entry »

Top Industry Stories – August 24, 2010

Posted on August 24th, 2010 | by Rxmedyn | No Comments »

U.S. Judge Rules Against Obama’s Stem Cell Policy

Headed to ER? Some Post Waits by Text, Billboard

Vit D Linked to Cancer, Autoimmune Disease Genes

U.S. Probes Egg Recall Amid Calls for Tighter Rules

Roche’s Avastin Again Fails to Win U.K. Panel Backing in Colorectal Cancer

Read the rest of this entry »

Top Industry Stories – August 23, 2010

Posted on August 23rd, 2010 | by Rxmedyn | No Comments »

Fixing a World That Fosters Fat

Patients Should Stay on Pfizer’s Lipitor, Not Switch to Generic, Study Say

New Health Plans for Uninsured off to Slow Start

FDA Chief on Salmonella: Agency Needs More Authority

Your Health: Got Allergies? Maybe it’s Actually Non-Allergic Rhinitis

Read the rest of this entry »

Top Industry Stories – August 20, 2010

Posted on August 20th, 2010 | by Rxmedyn | No Comments »

Lilly Moves Closer to Approval to Market Cymbalta for Chronic Pain

Reanimated ‘Junk’ DNA Is Found to Cause Disease

Glaxo Memo on Avandia Is Questioned

Painkiller Use Linked to Stroke Risk

More U.S. Teens Get Vaccinated, CDC Finds

Read the rest of this entry »

Top Industry Stories – August 19, 2010

Posted on August 19th, 2010 | by Rxmedyn | No Comments »

Palliative Care Extends Life, Study Finds

Doubt on Tactic in Alzheimer’s Battle

Johnson & Johnson Moves to Ensure Drug Safety

Premiums Rise $1 for Medicare Drug Plans

Survey: Big Employers Expect 2011 Health Cost Hike

Read the rest of this entry »

Top Industry News – August 18, 2010

Posted on August 18th, 2010 | by Rxmedyn | No Comments »

Bills Would Ban Drugmaker Deals to Delay Cheap Drugs

End to COBRA Subsidy Means Higher Health Insurance Bills

Lilly Alzheimer Failure Threatens Prospects for Similar Drugs

CSL Projects Profit Drop as Swine Flu Pandemic Ends, Cutting Vaccine Sales

Scientists Suggest Fresh Look at Psychedelic Drugs

Read the rest of this entry »